The Effect of Weekly GH replacement therapy on long-term glycemic variability -prospective observational study-

Effect of Once-Weekly GH replacement therapy on long-term glycemic variability - a single center prospective observational study -

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1031230186

Enrollment

Registered

2023-06-28

Start date

2023-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Severe adult growth hormone deficiency Adult growth hormone deficiency

Interventions

None

Eligibility

Inclusion criteria

Inclusion criteria: Patients who participated in a previous study (C21-062).

Exclusion criteria

Exclusion criteria: Patients with serious trauma before or after surgery, obvious malignant tumor complications, pregnant and under 20 years old or over 80 years old

Design outcomes

Primary

Measure	Time frame
The %CV (before and 3 months after the introduction of sogroya ) obtained in the previous study (C21-062) will be compared with the %CV at the time of participation in this study.	—

Secondary

Measure	Time frame
Comparison of HbA1c, GA, and fasting blood glucose Comparison of body composition Comparison of CONGA , SD, and mean blood glucose	—

Contacts

Public ContactHaremaru Kubo

Kitasato University Hospital

kubo.haremaru@kitasato-u.ac.jp+81-42-778-8111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026